TOI · Oncology Institute, Inc.

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Cap structure and valuation

Cap structure
SP	$5.72
SO	100.0M
Options	3.9M
Warrants	16.2M
FD SO	120.1M
MC	$687.1M

Cash	$30.3M
Total debt	$78.7M
EV	$735.5M

TTM Multiples
EV / Revenue	1.3x
EV / EBITDA	—
MC / Net Income	—
EV / FCF	—
MC / FCF	—

Ownership & coverage
Institutional	45.8%
Insiders	18.2%
# Institutions	150
Analysts	5
Consensus	Strong Buy
Avg target	$8.40

Short % float	7.8%
Days to cover	3.35

MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-04-30. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-07-13 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-06-29; the float denominator can be unreliable on tiny floats.

Financial statements

	3/31/26	12/31/25	9/30/25	6/30/25
Total Revenue	147.44	141.96	136.56	119.80
Revenue YoY %	41.2%	41.6%	36.7%	21.5%
Gross Profit	21.70	21.13	17.20	15.70
Gross Profit YoY %	40.3%	63.5%	34.4%	36.4%
Gross Margin %	14.7%	14.9%	12.6%	13.1%

SG&A	28.21	28.04	25.25	26.91

Operating Income	(6.51)	(6.91)	(8.05)	(11.21)
Operating Income YoY %	34.3%	42.1%	41.9%	31.5%
Operating Margin %	(4.4%)	(4.9%)	(5.9%)	(9.4%)
EBITDA	(4.90)	(5.28)	(6.33)	(9.41)
EBITDA Margin %	(3.3%)	(3.7%)	(4.6%)	(7.9%)

Interest Expense	1.93	1.92	1.92	1.87
Other Income / (Expense)	5.96	1.31	(6.53)	(4.06)
Pretax Income	(2.49)	(7.51)	(16.50)	(17.14)
Tax Provision	0.00	0.00	0.00	(0.13)
Net Income	(2.49)	(7.51)	(16.50)	(17.01)
Net Margin %	(1.7%)	(5.3%)	(12.1%)	(14.2%)

Diluted EPS	-$0.02	-$0.05	-$0.14	-$0.15
Basic EPS	-$0.02	-$0.05	-$0.14	-$0.15
Diluted Avg Shares	101.8	—	97.5	93.2
Basic Avg Shares	101.8	—	97.5	93.2

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Total Revenue	545.76	502.73	393.41	324.24	252.48
Revenue YoY %	8.6%	27.8%	21.3%	28.4%	—
Gross Profit	75.72	69.49	47.71	36.83	37.74
Gross Profit YoY %	9.0%	45.7%	29.5%	(2.4%)	—
Gross Margin %	13.9%	13.8%	12.1%	11.4%	14.9%

SG&A	108.41	105.57	107.83	113.85	119.69

Operating Income	(32.69)	(36.08)	(60.12)	(77.02)	(81.95)
Operating Income YoY %	9.4%	40.0%	21.9%	6.0%	—
Operating Margin %	(6.0%)	(7.2%)	(15.3%)	(23.8%)	(32.5%)
EBITDA	(25.91)	(29.14)	(53.83)	(71.14)	(77.54)
EBITDA Margin %	(4.7%)	(5.8%)	(13.7%)	(21.9%)	(30.7%)

Interest Expense	7.64	11.28	7.50	6.78	(4.08)
Other Income / (Expense)	(3.32)	(13.38)	2.95	0.69	77.78
Pretax Income	(43.64)	(60.74)	(64.66)	(83.10)	(0.09)
Tax Provision	(0.13)	(0.13)	0.00	(0.04)	(0.24)
Net Income	(43.51)	(60.61)	(64.66)	(83.07)	0.15
Net Margin %	(8.0%)	(12.1%)	(16.4%)	(25.6%)	0.1%

Diluted EPS	-$0.36	-$0.54	-$0.71	-$0.92	-$0.21
Basic EPS	-$0.36	-$0.54	-$0.71	-$0.92	$0.00
Diluted Avg Shares	101.8	92.4	75.0	73.7	80.6
Basic Avg Shares	101.8	92.4	75.0	73.7	72.8

	3/31/26	12/31/25	9/30/25	6/30/25
Cash & Equivalents	30.28	33.56	27.66	30.29
Receivables	58.13	59.00	59.64	55.66
Inventory	24.29	16.88	18.88	15.79
Other Current Assets	4.16	3.31	3.91	3.06
Total Current Assets	116.86	112.75	110.09	104.79

Net PPE	10.70	10.68	10.71	10.85
Operating Lease ROU	22.52	22.37	23.27	23.89
Goodwill	7.23	7.23	7.23	7.23
Intangible Assets	10.30	11.02	11.73	12.45
Total Assets	168.23	164.66	163.62	159.80

Accounts Payable	47.65	43.17	35.63	34.93
Current Lease Liabilities	7.40	7.16	7.16	6.95
Other Current Liabilities	24.30	20.64	22.79	22.89
Total Current Liabilities	79.35	70.96	65.58	64.78
Long-term Debt	78.61	77.40	76.19	75.02
Long-term Lease Liabilities	18.84	19.13	20.20	21.18
Other Liabilities	7.71	12.88	13.92	7.80
Total Liabilities	184.51	180.38	175.89	168.78

Retained Earnings	(273.91)	(271.42)	(263.91)	(247.41)
Total Equity	(16.29)	(15.72)	(12.27)	(8.98)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Cash & Equivalents	30.28	33.56	49.67	33.49	14.01
Short-term Investments	—	—	0.00	49.37	59.80
Receivables	58.13	59.00	48.34	42.36	39.82
Inventory	24.29	16.88	10.04	13.68	9.26
Other Current Assets	4.16	3.31	4.38	4.60	7.54
Total Current Assets	116.86	112.75	112.42	143.49	130.42

Net PPE	10.70	10.68	11.89	10.88	8.55
Operating Lease ROU	22.52	22.37	25.78	29.17	24.49
Goodwill	7.23	7.23	7.23	7.23	21.42
Intangible Assets	10.30	11.02	14.81	17.90	17.96
Long-term Investments	—	—	—	0.00	58.35
Total Assets	168.23	164.66	172.72	209.24	261.67

Accounts Payable	47.65	43.17	24.32	14.43	9.37
Current Debt	—	—	—	—	0.00
Current Lease Liabilities	7.40	7.16	6.80	6.36	5.50
Other Current Liabilities	24.30	20.64	21.09	14.00	14.85
Total Current Liabilities	79.35	70.96	52.22	34.79	29.72
Long-term Debt	78.61	77.40	93.13	86.83	80.62
Long-term Lease Liabilities	18.84	19.13	23.22	26.49	22.06
Other Liabilities	7.71	12.88	—	4.12	6.09
Total Liabilities	184.51	180.38	169.13	152.22	138.49

Retained Earnings	(273.91)	(271.42)	(210.81)	(146.15)	(63.08)
Total Equity	(16.29)	(15.72)	3.59	57.02	123.17

	3/31/26	12/31/25	9/30/25	6/30/25
Net Income	(2.49)	(7.51)	(16.50)	(17.01)
D&A	1.62	1.63	1.72	1.80
Stock-Based Comp	1.69	1.32	1.02	0.75
Δ Working Cap & Other	(3.02)	7.79	1.13	4.25
Operating Cash Flow	(2.21)	3.23	(12.63)	(10.20)

CapEx	(1.04)	(1.06)	(0.60)	(1.21)
Investing Cash Flow	(1.04)	(1.06)	(0.60)	(1.21)

Debt Repayment	0.00	0.00	0.00	0.00
Stock Issuance	—	3.89	7.61	2.20
Other Financing	—	—	2.99	—
Financing Cash Flow	(0.03)	3.73	10.60	1.96

Free Cash Flow	(3.26)	2.17	(13.23)	(11.41)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Net Income	(43.51)	(60.61)	(64.66)	(83.07)	0.15
D&A	6.78	6.94	6.29	5.87	4.41
Stock-Based Comp	4.78	4.55	11.15	17.81	27.68
Δ Working Cap & Other	10.14	24.52	20.69	23.07	(94.00)
Operating Cash Flow	(21.81)	(24.59)	(26.54)	(36.31)	(61.76)

CapEx	(3.91)	(3.20)	(3.79)	(4.57)	(5.53)
Acquisitions	—	—	0.00	(4.46)	(8.58)
Other Investing	—	—	50.00	71.66	(117.51)
Investing Cash Flow	(3.91)	(3.07)	46.21	62.64	(131.61)

Debt Issuance	—	—	—	0.00	110.00
Debt Repayment	0.00	(20.00)	0.00	—	0.00
Stock Issuance	—	13.84	0.00	0.13	—
Stock Buyback	—	—	0.00	(1.02)	(9.00)
Other Financing	16.27	17.72	(3.49)	(5.95)	(8.79)
Financing Cash Flow	16.27	11.56	(3.49)	(6.85)	92.21

Free Cash Flow	(25.73)	(27.79)	(30.33)	(40.88)	(67.28)

	3/31/26	12/31/25	9/30/25	6/30/25
Current Ratio	1.47	1.59	1.68	1.62
Quick Ratio	1.17	1.35	1.39	1.37
Debt / Equity	-11.33	-11.47	-14.33	-18.78
EBITDA Margin %	(3.3%)	(3.7%)	(4.6%)	(7.9%)
Working Capital	37.51	41.78	44.51	40.01
Net Debt	48.33	43.84	48.54	44.73
ROE %	15.3%	47.8%	134.5%	189.3%
ROA %	(1.5%)	(4.6%)	(10.1%)	(10.6%)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Current Ratio	1.47	1.59	2.15	4.12	4.39
Quick Ratio	1.17	1.35	1.96	3.73	4.08
Debt / Equity	-11.33	-11.47	47.12	2.67	1.12
EBITDA Margin %	(4.7%)	(5.8%)	(13.7%)	(21.9%)	(30.7%)
Working Capital	37.51	41.78	60.20	108.70	100.70
Net Debt	48.33	43.84	43.46	53.34	66.61
ROE %	267.2%	385.5%	(1801.7%)	(145.7%)	0.1%
ROA %	(25.9%)	(36.8%)	(37.4%)	(39.7%)	0.1%

Insider activity (last 2 years)

Date Filed	Reporter	Relationship	Trans. Date	Code	Shares	Price	Total Value
2026-06-24	Chernett Jorey	10% Owner	2026-06-23	P	18,000	$5.02	$90,360
2026-06-09	Podnos Yale	Officer (Chief Medical Officer)	2026-06-08	S	(23,451)	$5.38	-$126,094
2026-06-05	Chernett Jorey	10% Owner	2026-06-04	P	12,000	$4.75	$57,000
2026-05-22	Podnos Yale	Officer (Chief Medical Officer)	2026-05-21	J	(1,805)	$4.47	-$8,068
2026-05-22	Virnich Daniel	Officer (Chief Executive Officer)	2026-05-21	J	(23,058)	$4.47	-$103,069
2026-05-22	Carter Robert Ross	Officer (Chief Financial Officer)	2026-05-21	J	(1,604)	$4.47	-$7,170
2026-05-21	Chernett Jorey	10% Owner	2026-05-20	P	33,500	$4.07	$136,345
2026-05-21	Chernett Jorey	10% Owner	2026-05-19	P	5,000	$4.05	$20,250
2026-05-20	Chernett Jorey	10% Owner	2026-05-19	P	30,000	$4.09	$122,700
2026-04-16	Kaushal Mohit	Director	2026-04-16	S	(38,433)	$3.50	-$134,535
2026-04-16	Kaushal Mohit	Director	2026-04-14	S	(57,286)	$3.50	-$200,598
2026-04-13	Chernett Jorey	10% Owner	2026-04-09	P	20,000	$3.10	$62,000
2026-04-01	Langsam Jeffrey	Officer (Chief Clinical Officer)	2026-03-27	A	70,270	—	$0
2026-04-01	England Kristin	Officer (Chief Administrative Officer)	2026-03-27	A	55,743	—	$0
2026-04-01	Podnos Yale	Officer (Chief Medical Officer)	2026-03-27	A	66,446	—	$0
2026-04-01	Podnos Yale	Officer (Chief Medical Officer)	2026-03-27	J	(16,173)	$3.07	-$49,651
2026-04-01	Carter Robert Ross	Officer (Chief Financial Officer)	2026-03-27	A	(202,914)	—	$-0
2026-04-01	Carter Robert Ross	Officer (Chief Financial Officer)	2026-03-27	J	(20,320)	$3.07	-$62,382
2026-04-01	Virnich Daniel	Officer (Chief Executive Officer)	2026-03-27	A	(670,608)	—	$-0
2026-04-01	Virnich Daniel	Officer (Chief Executive Officer)	2026-03-27	J	(98,534)	$3.07	-$302,499
2026-03-30	Chernett Jorey	10% Owner	2026-03-27	P	27,429	$2.96	$81,190
2026-03-27	Chernett Jorey	10% Owner	2026-03-26	P	50,000	$3.15	$157,500
2026-03-25	Chernett Jorey	10% Owner	2026-03-24	P	125,000	$3.11	$388,750
2026-03-23	Chernett Jorey	10% Owner	2026-03-20	P	25,000	$3.35	$83,750
2026-03-18	Virnich Daniel	Officer (Chief Executive Officer)	2026-03-17	J	(11,834)	$3.59	-$42,484
2026-03-18	Carter Robert Ross	Officer (Chief Financial Officer)	2026-03-17	J	(1,314)	$3.59	-$4,717
2026-03-18	Podnos Yale	Officer (Chief Medical Officer)	2026-03-17	J	(3,420)	$3.59	-$12,278
2026-03-17	Chernett Jorey	10% Owner	2026-03-17	P	75,000	$3.42	$256,500
2026-03-17	Chernett Jorey	10% Owner	2026-03-16	P	60,985	$3.29	$200,641
2026-03-17	Chernett Jorey	10% Owner	2026-03-13	P	263,000	$2.92	$767,960
2026-01-06	Carter Robert Ross	Officer (Chief Financial Officer)	2026-01-02	J	(244)	$3.67	-$895
2026-01-05	Carter Robert Ross	Officer (Chief Financial Officer)	2026-01-02	S	(247)	$3.56	-$879
2025-12-16	Hively Brad	Director	2025-12-15	S	(13,333)	$3.77	-$50,291
2025-11-24	McGeorge Anne	Director	2025-11-20	A	67,901	—	$0
2025-11-24	McGeorge Anne	Director	2025-11-20	A	40,123	—	$0
2025-11-24	Kaushal Mohit	Director	2025-11-20	A	50,926	—	$0
2025-11-24	Kaushal Mohit	Director	2025-11-20	A	40,123	—	$0
2025-11-24	Ling Gabriel	Director	2025-11-20	A	46,296	—	$0
2025-11-24	Ling Gabriel	Director	2025-11-20	A	37,037	—	$0
2025-11-24	Johnson Karen Marie	Director	2025-11-20	A	47,840	—	$0
2025-11-24	Johnson Karen Marie	Director	2025-11-20	A	37,037	—	$0
2025-11-24	Pacala Mark L	Director	2025-11-20	A	46,296	—	$0
2025-11-24	Pacala Mark L	Director	2025-11-20	A	35,494	—	$0
2025-11-24	Hively Brad	Director	2025-11-20	A	41,667	—	$0
2025-11-24	Hively Brad	Director	2025-11-20	A	32,407	—	$0
2025-11-20	Pacala Mark L	Director	2025-11-18	S	(2,160)	$4.00	-$8,640
2025-11-20	Pacala Mark L	Director	2025-11-18	S	(1,210)	$4.00	-$4,840
2025-11-20	Pacala Mark L	Director	2025-11-18	S	(46,630)	$4.00	-$186,520
2025-11-20	Ling Gabriel	Director	2025-11-18	J	141,149	—	$0
2025-11-20	M33 Growth I L.P.	Director	2025-11-18	J	(590,892)	—	$-0
2025-11-20	M33 Growth I L.P.	Director	2025-11-18	J	11,818	—	$0
2025-11-20	M33 Growth I L.P.	Director	2025-11-18	J	(2,500,000)	—	$-0
2025-11-19	Virnich Daniel	Officer (Chief Executive Officer)	2025-11-17	A	6,464	—	$0
2025-11-19	Podnos Yale	Officer (Chief Medical Officer)	2025-11-17	A	2,086	—	$0
2025-11-19	Carter Robert Ross	Officer (Chief Financial Officer)	2025-11-17	A	195	—	$0
2025-11-14	Virnich Daniel	Officer (Chief Executive Officer)	2025-11-12	A	6,211	—	$0
2025-11-14	Podnos Yale	Officer (Chief Medical Officer)	2025-11-12	A	306	—	$0
2025-11-14	Podnos Yale	Officer (Chief Medical Officer)	2025-11-12	A	1,202	—	$0
2025-09-05	M33 Growth I L.P.	Director, 10% Owner	2025-09-04	S	(6,018,168)	$3.09	-$18,596,139
2025-09-05	M33 Growth I L.P.	Director, 10% Owner	2025-09-04	S	(681,832)	$3.09	-$2,106,861
2025-08-21	Hively Brad	Director	2025-08-19	S	(20,221)	$4.06	-$82,097
2025-07-28	BARASCH RICHARD A	Director	2025-07-24	J	(287,756)	—	$-0
2025-07-24	England Kristin	Officer (Chief Administrative Officer)	2025-07-22	A	98,037	—	$0
2025-06-24	BARASCH RICHARD A	Director	2025-06-17	X	679,224	$1.20	$813,710
2025-06-24	BARASCH RICHARD A	Director	2025-06-17	F	(311,128)	$2.62	-$813,724
2025-06-24	BARASCH RICHARD A	Director	2025-06-17	X	(679,224)	—	$-0
2025-06-20	BARASCH RICHARD A	Director	2025-06-18	C	620,400	—	$0
2025-06-20	BARASCH RICHARD A	Director	2025-06-18	C	(6,204)	—	$-0
2025-06-20	BARASCH RICHARD A	Director	2025-06-17	C	159,500	—	$0
2025-06-20	BARASCH RICHARD A	Director	2025-06-17	C	(1,595)	—	$-0
2025-06-09	M33 Growth I L.P.	Director, 10% Owner	2025-06-05	S	(673,676)	$3.05	-$2,054,712
2025-06-09	M33 Growth I L.P.	Director, 10% Owner	2025-06-05	S	(76,324)	$3.05	-$232,788
2025-06-05	Hively Brad	Director	2025-06-03	M	684,528	$0.85	$581,849
2025-06-05	Hively Brad	Director	2025-06-03	M	105,320	$0.48	$50,659
2025-06-05	Hively Brad	Director	2025-06-03	M	131,297	$1.87	$245,525
2025-06-05	Hively Brad	Director	2025-06-03	M	946,460	$0.85	$804,491
2025-06-05	Hively Brad	Director	2025-06-03	S	(1,867,605)	$2.87	-$5,360,587
2025-06-05	Hively Brad	Director	2025-06-03	S	(108,532)	$2.87	-$311,519
2025-06-05	Hively Brad	Director	2025-06-03	M	684,528	—	$0
2025-06-05	Hively Brad	Director	2025-06-03	M	105,320	—	$0
2025-06-05	Hively Brad	Director	2025-06-03	M	131,297	—	$0
2025-06-05	Hively Brad	Director	2025-06-03	M	946,460	—	$0
2025-05-23	Langsam Jeffrey	Officer (Chief Clinical Officer)	2025-05-21	A	57,380	—	$0
2025-05-22	Virnich Daniel	Officer (Chief Executive Officer)	2025-05-21	D	(20,388)	$2.67	-$54,538
2025-05-22	Podnos Yale	Officer (Chief Medical Officer)	2025-05-21	D	(1,801)	$2.67	-$4,818
2025-05-22	Carter Robert Ross	Officer (Chief Financial Officer)	2025-05-21	D	(1,601)	$2.67	-$4,283
2025-05-22	Castle Jeremy	Officer (Chief Operating Officer)	2025-05-21	D	(5,636)	$2.67	-$15,076
2025-05-22	M33 Growth I L.P.	Director, 10% Owner	2025-05-20	S	(1,796,468)	$2.71	-$4,873,638
2025-05-22	M33 Growth I L.P.	Director, 10% Owner	2025-05-20	S	(203,532)	$2.71	-$552,162
2025-04-28	Hively Brad	Director	2025-03-26	P	45,280	$1.04	$47,168
2025-04-28	Hively Brad	Director	2025-03-26	P	22,640	$0.12	$2,830
2025-04-02	Podnos Yale	Officer (Chief Medical Officer)	2025-03-31	A	157,088	—	$0
2025-04-02	Carter Robert Ross	Officer (Chief Financial Officer)	2025-03-31	A	197,368	—	$0
2025-04-02	Castle Jeremy	Officer (Chief Operating Officer)	2025-03-31	A	162,281	—	$0
2025-04-02	Virnich Daniel	Officer (Chief Executive Officer)	2025-03-31	A	1,083,334	—	$0
2025-03-28	M33 Growth I L.P.	Director, 10% Owner	2025-03-26	A	2,716,898	$1.04	$2,830,193
2025-03-28	M33 Growth I L.P.	Director, 10% Owner	2025-03-26	A	1,358,449	$0.12	$169,806
2025-03-28	Virnich Daniel	Officer (Chief Executive Officer)	2025-03-26	P	22,640	$1.04	$23,584
2025-03-28	Virnich Daniel	Officer (Chief Executive Officer)	2025-03-26	P	11,320	$0.12	$1,415
2025-03-28	Podnos Yale	Officer (Chief Medical Officer)	2025-03-26	P	9,056	$1.04	$9,434
2025-03-28	Podnos Yale	Officer (Chief Medical Officer)	2025-03-26	P	4,528	$0.12	$566
2025-03-28	Pacala Mark L	Director	2025-03-26	P	90,562	$1.04	$94,338
2025-03-28	Pacala Mark L	Director	2025-03-26	P	42,281	$0.12	$5,285
2025-03-28	Johnson Karen Marie	Director	2025-03-26	P	36,224	$1.04	$37,735
2025-03-28	Johnson Karen Marie	Director	2025-03-26	P	18,112	$0.12	$2,264
2025-03-28	Hively Brad	Director	2025-03-26	P	9,056	$1.04	$9,434
2025-03-28	Hively Brad	Director	2025-03-26	P	4,528	$0.12	$566
2025-03-28	Castle Jeremy	Officer (Chief Operating Officer)	2025-03-26	P	9,056	$1.04	$9,434
2025-03-28	Castle Jeremy	Officer (Chief Operating Officer)	2025-03-26	P	4,528	$0.12	$566
2025-03-28	Carter Robert Ross	Officer (Chief Financial Officer)	2025-03-26	P	9,056	$1.04	$9,434
2025-03-28	Carter Robert Ross	Officer (Chief Financial Officer)	2025-03-26	P	4,528	$0.12	$566
2025-03-28	BARASCH RICHARD A	Director	2025-03-26	P	1,358,448	$1.04	$1,415,095
2025-03-28	BARASCH RICHARD A	Director	2025-03-26	P	679,224	$0.12	$84,903
2025-03-20	Virnich Daniel	Officer (Chief Executive Officer)	2025-03-19	D	(10,261)	$0.89	-$9,122
2025-03-20	Podnos Yale	Officer (Chief Medical Officer)	2025-03-19	D	(2,975)	$0.89	-$2,645
2025-03-20	Carter Robert Ross	Officer (Chief Financial Officer)	2025-03-19	D	(1,150)	$0.89	-$1,022
2025-01-07	Carter Robert Ross	Officer (Chief Financial Officer)	2025-01-06	D	(258)	$0.34	-$86
2024-12-05	Castle Jeremy	Officer (Chief Operating Officer)	2024-12-03	D	(1,130)	$0.16	-$181
2024-12-02	Hively Brad	Director	2024-12-02	P	50,000	$0.15	$7,500
2024-12-02	Hively Brad	Director	2024-11-26	P	250,000	$0.17	$42,500
2024-12-02	Hively Brad	Director	2024-11-12	J	(353,450)	—	$-0
2024-11-25	BARASCH RICHARD A	Director	2024-11-22	A	80,000	—	$0
2024-11-25	Pacala Mark L	Director	2024-11-22	A	50,000	—	$0
2024-11-25	McGeorge Anne	Director	2024-11-22	A	56,000	—	$0
2024-11-25	Johnson Karen Marie	Director	2024-11-22	A	52,000	—	$0
2024-11-25	Kaushal Mohit	Director	2024-11-22	A	56,000	—	$0
2024-11-25	Ling Gabriel	Director	2024-11-22	A	40,000	—	$0
2024-11-25	Hively Brad	Director	2024-11-22	A	44,000	—	$0
2024-11-21	Virnich Daniel	Officer (Chief Executive Officer)	2024-11-20	D	(4,750)	$0.14	-$646
2024-11-21	Virnich Daniel	Officer (Chief Executive Officer)	2024-11-20	D	(4,977)	$0.14	-$677
2024-11-21	Carter Robert Ross	Officer (Chief Financial Officer)	2024-11-20	D	(235)	$0.14	-$32
2024-11-21	Podnos Yale	Officer (Chief Medical Officer)	2024-11-20	D	(1,709)	$0.14	-$232
2024-11-21	Podnos Yale	Officer (Chief Medical Officer)	2024-11-20	D	(267)	$0.14	-$36
2024-11-21	Podnos Yale	Officer (Chief Medical Officer)	2024-11-20	D	(1,026)	$0.14	-$140
2024-11-18	Podnos Yale	Officer (Chief Medical Officer)	2024-11-12	J	(11,359)	—	$-0
2024-11-18	Podnos Yale	Officer (Chief Medical Officer)	2024-11-12	J	(17,039)	—	$-0
2024-11-18	Pacala Mark L	Director	2024-11-12	J	(20,248)	—	$-0
2024-11-18	Pacala Mark L	Director	2024-11-12	J	(30,372)	—	$-0
2024-11-18	Virnich Daniel	Officer (Chief Executive Officer)	2024-11-12	J	(78,094)	—	$-0
2024-11-18	Virnich Daniel	Officer (Chief Executive Officer)	2024-11-12	J	(117,142)	—	$-0
2024-08-20	Havencrest Healthcare Partners, L.P.	10% Owner	2024-08-16	J	(8,701,823)	—	$-0
2024-08-20	Havencrest Healthcare Partners, L.P.	10% Owner	2024-08-16	J	(7,631,418)	—	$-0